https://wiki.tradeville.ro/index.php?action=history&feed=atom&title=MEDIGENE_AGMEDIGENE AG - Revizia istoricului2026-04-10T13:25:23ZIstoricul versiunilor pentru această pagină din wikiMediaWiki 1.39.2https://wiki.tradeville.ro/index.php?title=MEDIGENE_AG&diff=355511&oldid=prevAdmin: Pagină nouă: Pagina dedicata companiei MEDIGENE AG listata cu simbolul DE.MDG1 ==Descriere companie== Medigene AG (www.medigene.com/home) is a Germany-based biotechnology company that develops treatment platforms to target various types and stages of cancer with candidates in clinical and pre-clinical development. The Company focuses on the development of personalized T cell-based immunotherapies. It develops three platforms: T-cell receptor (TCR)-modified T cells for adoptive T-cell th...2024-09-18T12:18:04Z<p>Pagină nouă: Pagina dedicata companiei MEDIGENE AG listata cu simbolul DE.MDG1 ==Descriere companie== Medigene AG (www.medigene.com/home) is a Germany-based biotechnology company that develops treatment platforms to target various types and stages of cancer with candidates in clinical and pre-clinical development. The Company focuses on the development of personalized T cell-based immunotherapies. It develops three platforms: T-cell receptor (TCR)-modified T cells for adoptive T-cell th...</p>
<p><b>Pagină nouă</b></p><div>Pagina dedicata companiei MEDIGENE AG listata cu simbolul DE.MDG1<br />
<br />
==Descriere companie==<br />
Medigene AG (www.medigene.com/home) is a Germany-based biotechnology company that develops treatment platforms to target various types and stages of cancer with candidates in clinical and pre-clinical development. The Company focuses on the development of personalized T cell-based immunotherapies. It develops three platforms: T-cell receptor (TCR)-modified T cells for adoptive T-cell therapy as treatments for patients with tumor burdens; Dendritic cell (DC) vaccines for the treatment of low tumor burdens, such as minimal residual disease or for use in combination therapies, and T-cell-specific monoclonal antibodies (TABS) to identify T cells based on their T-cell receptors. The Company operates offices in Martinsried in Germany, as well as in Washington DC and San Diego in the United States.<br />
<br />
==Grafic actiuni companie==<br />
<iframe key="tradeville" path="graficSimbol/DE.MDG1" /><br />
<br />
==Ultimele stiri despre MEDIGENE AG (DE.MDG1)==<br />
<dynamicpagelist><br />
category=DE.MDG1<br />
count=10<br />
order=descending<br />
addfirstcategorydate=false<br />
</dynamicpagelist><br />
<br />
[[Categorie:DE.MDG1]][[Categorie:Stiri despre companii]]</div>Admin